Astec Lifesciences Ltd share price softened by 2.27% to Rs 627.85 after the company's net profit saw a strong growth of 141.42% to Rs 18.71 crore, while revenue from operations nosedived 47.32% to Rs 83.56 crore in Q2FY26 over Q1FY26. The market capitalization of Pesticides & Agrochemicals industry group stocks on BSE stood at Rs 1.92 lakh crore, jumping 30.65%. It has slipped by 2.51% over last one week and eased lower by 6.68% in last one month while the market capitalization of Astec Lifesciences Ltd has eased by 4.74% and 9.98% in the same period respectively. Profit before tax (PBT) of Astec Lifesciences Ltd stood at Rs 18.74 crore in Q2 FY26, plunging by 43.25% year-on-year, and surging by 137.22% quarter-on-quarter. EBITDA came in at Rs 1 crore, crashing by 87.91% YoY and tanking 121.29% sequentially. Total expenses slumped by 40.89% to Rs 95.3 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 76.32 crore, growing marginally by 7.09% YoY, while employee benefits expense was at Rs 16.0 crore, slipping by 1.96% YoY. For the TTM ended FY26, revenue from operations grew 17.53% to Rs 448.15 crore, while net profit plunged by 39.96% to Rs 80.88 crore, compared to previous TTM. EBITDA saw a sharp decline of 7163% to Rs 9.6 crore, and PBT tumbled by 42.55% to Rs 81.0 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 80.71 crore in FY26, as against Rs 8.4 crore in FY25. Astec Lifesciences Ltd nosedived by 27.14% in last one year, underperforming the benchmark BSE Sensex which has eased by 4.36% during the same period.
